In particular, for the COVID-19 vaccine nanovesicle, the TFH subset assists S protein-specific B lymphocytes to differentiate into antibody-secreting plasmocytes and endorse the production of high-affinity anti-S protein antibodies [65,76]. This evidence concerns the gene PROS1 and COVID-19.